Dabur's Silvassa plant flagged by US FDA under Import Alert 66-40 over data integrity gaps
US FDA placed select private-label exports from Dabur's Silvassa facility under Import Alert 66-40, citing data integrity concerns. Dabur calls the financial hit immaterial, says domestic products and plant operations are unaffected, and has arranged alternative sourcing for the US market. Shares trade at ₹423, down 1.15% intraday and 15% YTD 2026.
What happened
Dabur India · US FDA placed certain private-label products from Dabur's Silvassa facility under Import Alert 66-40 citing data integrity gaps. Dabur says impact
Key facts
- Import Alert 66-40
- ₹423
- -1.15%
- -15% YTD 2026
- June 10, 2026
Why this matters
US private-label contract manufacturing is now a contested slot — scope alternative-sourcing partnerships or acquisition targets with clean FDA records to capture displaced Dabur volumes before rivals lock them in.